Moderna has further expanded its deal with Lonza this week, with an agreement to establish a production line at Lonza’s Geleen site in the Netherlands. Once operational (expected by the end of the year), the line will produce an additional 300 million doses ofModerna’s updated booster vari...
"Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19," he said. Coronavirus Pandemic More FDA authorizes over-the-counter combined COVID-19 and flu test ...
The US drug company Moderna has announced that it is developing two new approaches to emerging variants of covid-19 after studies showed that its vaccine had a reduced level of neutralising titres to the South African variant, suggesting that immunity might wane. Although the studies showed that...
WASHINGTON, Dec. 20 (Xinhua) -- American biotechnology company Moderna announced Monday that preliminary data suggests its COVID-19 booster shot appears to increase antibody levels against the Omicron coronavirus variant. The currently authorized 50-microgram booster of Moderna's COVID-19 vaccine mRNA...
The objective of the study was to assess the safety and immunogenicity of mRNA-1273 COVID-19 booster vaccination when co-administered with an egg-based standard dose seasonal quadrivalent influenza vaccine (QIV). This was a phase 3, randomized, open-label study. Eligible adults aged ≥ 18...
Two of Moderna’s COVID-19 vaccine booster shots under study induced an immune response against SARS-CoV-2 and variants first identified in South Africa and Brazil, the company announced Wednesday. A variant-specific booster shot resulted in higher levels of neutralizing antibodies against the conce...
[1]https://www.dailymail.co.uk/health/article-11624959/FDA-CDC-vaccine-advisers-angry-early-data-Covid-19-booster-shot-withheld-year.html [2]Chalkias S, Eder F, Essink B,et al. Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19...
The news of the booster comes just a month after Moderna said it was working on one. Like its first COVID-19 jab, the new vaccine candidate was also created using groundbreaking mRNA technology. In addition to Moderna, other vaccine makers — including Pfizer, the creator of the first COVI...
- Moderna’s COVID-19 vaccine remained 93% effective against symptomatic illness six months after the second dose, but amid the ongoing spread of the highly contagious delta variant, the company said it believes a booster dose will be necessary prior to the winter season. The company a...
Sep 11, 2023ApprovalModerna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Dec 8, 2022Moderna Receives FDA Emergency Use Authorization for Omicron-Targeting Bivalent COVID-19 Booster Vaccine in Children 6 Months Through 5 Years of Age ...